Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in Pharma Business Management and Research : Volume 1 / / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen
| Advances in Pharma Business Management and Research : Volume 1 / / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen |
| Autore | Schweizer Lars |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Springer Nature, 2020 |
| Descrizione fisica | 1 online resource (X, 85 p. 11 illus.) |
| Disciplina | 615.19 |
| Soggetto topico |
Pharmaceutical technology
Health care management Health services administration Medical laws and legislation Pharmacy Pharmacy management Pharmaceutical Sciences/Technology Health Care Management Medical Law Pharmacoeconomics and Health Outcomes |
| Soggetto non controllato |
Pharmaceutical Sciences/Technology
Health Care Management Medical Law Pharmacy Pharmacoeconomics and Health Outcomes Pharmaceutics Health Care Pharmacology Pharma Management Market Access Regulatory Affairs Research & Development Quality Control Open Access Industrial chemistry & chemical engineering Health economics Medical & healthcare law Pharmacy / dispensing |
| ISBN | 3-030-35918-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. |
| Record Nr. | UNINA-9910380742003321 |
Schweizer Lars
|
||
| Springer Nature, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial peptides [[electronic resource] /] / David A. Phoenix, Sarah R. Dennison, and Frederick Harris
| Antimicrobial peptides [[electronic resource] /] / David A. Phoenix, Sarah R. Dennison, and Frederick Harris |
| Autore | Phoenix David A |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2013 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina |
572.65
615/.1 |
| Altri autori (Persone) |
DennisonSarah R
HarrisFrederick |
| Soggetto topico | Peptide antibiotics |
| Soggetto non controllato |
Medicine--Basic Sciences
Pharmacy |
| ISBN |
3-527-65285-X
3-527-65287-6 1-299-15730-0 3-527-65288-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Related Titles; Title page; Copyright page; Contents; Preface; References; List of Abbreviations; 1: Antimicrobial Peptides: Their History, Evolution, and Functional Promiscuity; Summary; 1.1 Introduction: The History of Antimicrobial Peptides; 1.2 AMPs: Evolutionarily Ancient Molecules; 1.3 AMPs: Multifunctional Molecules; 1.3.1 Defensins as Effectors of Immunity; 1.3.2 Defensins and Wound Healing; 1.3.3 Defensins and Canine Coat Color; 1.4 Discussion; References; 2: Cationic Antimicrobial Peptides; Summary; 2.1 Introduction; 2.2 CAMPs and Their Antimicrobial Action
2.3 CAMPs That Adopt an α-Helical Structure2.4 CAMPs That Adopt a β-Sheet Structure; 2.5 CAMPs That Adopt Extended Structures Rich in Specific Residues; 2.6 Discussion; References; 3: Anionic Antimicrobial Peptides; Summary; 3.1 Introduction; 3.2 AAMPs in the Respiratory Tract; 3.3 AAMPs in the Brain; 3.4 AAMPs in the Epidermis; 3.5 AAMPs in the Epididymis; 3.6 AAMPs in Blood Components; 3.7 AAMPs in the Gastrointestinal Tract and Food Proteins; 3.8 AAMPs and Their Structure-Function Relationships; 3.9 Discussion; References 4: Graphical Techniques to Visualize the Amphiphilic Structures of Antimicrobial PeptidesSummary; 4.1 Introduction; 4.2 Amphiphilic Structures Adopted by AMPs; 4.3 Qualitative Methods for Identifying Amphiphilic Structure; 4.4 Quantitative Techniques for Analyzing Amphiphilic Structure; 4.4.1 Techniques Based on Hydropathy Plot Analysis; 4.4.2 Techniques Based on Fourier Transforms; 4.4.3 Amphipathic Index; 4.4.4 Hydrophobic Moment Analysis; 4.4.5 Classification of Amphiphilic α-Helices Using the Approach of Segrest; 4.4.6 Amphiphilicity Profiling Analysis of Tilted α-Helices 4.4.7 Extended Hydrophobic Moment Plot Analysis of Tilted α-Helices4.4.8 Amphiphilicity Quantified Using the Approach of Keller; 4.4.9 Amphiphilicity Quantified Using the Approach of Brasseur; 4.5 Discussion; References; 5: Models for the Membrane Interactions of Antimicrobial Peptides; Summary; 5.1 Introduction; 5.2 CM-Associated Factors That Affect the Antimicrobial Action of α-CAMPs; 5.3 Mechanisms Used by CAMPs for Microbial Membrane Interaction; 5.4 Established Models for the Membrane Interactions of α-AMPs; 5.4.1 Barrel-Stave and Toroidal Pore Models 5.4.2 Carpet Mechanism and the Shai-Huang-Matsazuki Model5.5 Recent Novel Models for the Membrane Interactions of α-AMPs; 5.6 Tilted Peptide Mechanism; 5.7 Amyloidogenic Mechanisms; 5.8 Discussion; References; 6: Selectivity and Toxicity of Oncolytic Antimicrobial Peptides; Summary; 6.1 Introduction; 6.2 Peptide-Based Factors That Contribute to the Anticancer Action of Anticancer Peptides; 6.2.1 Sequence Length; 6.2.2 Net Positive Charge; 6.2.3 Hydrophobicity; 6.2.4 Amphiphilicity; 6.3 Membrane-Based Factors That Contribute to the Anticancer Action of ACPs; 6.3.1 Membrane Receptors 6.3.2 Cholesterol |
| Record Nr. | UNINA-9910141488903321 |
|
Phoenix David A
|
||
| Weinheim, : Wiley-VCH, c2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial peptides [[electronic resource] /] / David A. Phoenix, Sarah R. Dennison, and Frederick Harris
| Antimicrobial peptides [[electronic resource] /] / David A. Phoenix, Sarah R. Dennison, and Frederick Harris |
| Autore | Phoenix David A |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2013 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina |
572.65
615/.1 |
| Altri autori (Persone) |
DennisonSarah R
HarrisFrederick |
| Soggetto topico | Peptide antibiotics |
| Soggetto non controllato |
Medicine--Basic Sciences
Pharmacy |
| ISBN |
3-527-65285-X
3-527-65287-6 1-299-15730-0 3-527-65288-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Related Titles; Title page; Copyright page; Contents; Preface; References; List of Abbreviations; 1: Antimicrobial Peptides: Their History, Evolution, and Functional Promiscuity; Summary; 1.1 Introduction: The History of Antimicrobial Peptides; 1.2 AMPs: Evolutionarily Ancient Molecules; 1.3 AMPs: Multifunctional Molecules; 1.3.1 Defensins as Effectors of Immunity; 1.3.2 Defensins and Wound Healing; 1.3.3 Defensins and Canine Coat Color; 1.4 Discussion; References; 2: Cationic Antimicrobial Peptides; Summary; 2.1 Introduction; 2.2 CAMPs and Their Antimicrobial Action
2.3 CAMPs That Adopt an α-Helical Structure2.4 CAMPs That Adopt a β-Sheet Structure; 2.5 CAMPs That Adopt Extended Structures Rich in Specific Residues; 2.6 Discussion; References; 3: Anionic Antimicrobial Peptides; Summary; 3.1 Introduction; 3.2 AAMPs in the Respiratory Tract; 3.3 AAMPs in the Brain; 3.4 AAMPs in the Epidermis; 3.5 AAMPs in the Epididymis; 3.6 AAMPs in Blood Components; 3.7 AAMPs in the Gastrointestinal Tract and Food Proteins; 3.8 AAMPs and Their Structure-Function Relationships; 3.9 Discussion; References 4: Graphical Techniques to Visualize the Amphiphilic Structures of Antimicrobial PeptidesSummary; 4.1 Introduction; 4.2 Amphiphilic Structures Adopted by AMPs; 4.3 Qualitative Methods for Identifying Amphiphilic Structure; 4.4 Quantitative Techniques for Analyzing Amphiphilic Structure; 4.4.1 Techniques Based on Hydropathy Plot Analysis; 4.4.2 Techniques Based on Fourier Transforms; 4.4.3 Amphipathic Index; 4.4.4 Hydrophobic Moment Analysis; 4.4.5 Classification of Amphiphilic α-Helices Using the Approach of Segrest; 4.4.6 Amphiphilicity Profiling Analysis of Tilted α-Helices 4.4.7 Extended Hydrophobic Moment Plot Analysis of Tilted α-Helices4.4.8 Amphiphilicity Quantified Using the Approach of Keller; 4.4.9 Amphiphilicity Quantified Using the Approach of Brasseur; 4.5 Discussion; References; 5: Models for the Membrane Interactions of Antimicrobial Peptides; Summary; 5.1 Introduction; 5.2 CM-Associated Factors That Affect the Antimicrobial Action of α-CAMPs; 5.3 Mechanisms Used by CAMPs for Microbial Membrane Interaction; 5.4 Established Models for the Membrane Interactions of α-AMPs; 5.4.1 Barrel-Stave and Toroidal Pore Models 5.4.2 Carpet Mechanism and the Shai-Huang-Matsazuki Model5.5 Recent Novel Models for the Membrane Interactions of α-AMPs; 5.6 Tilted Peptide Mechanism; 5.7 Amyloidogenic Mechanisms; 5.8 Discussion; References; 6: Selectivity and Toxicity of Oncolytic Antimicrobial Peptides; Summary; 6.1 Introduction; 6.2 Peptide-Based Factors That Contribute to the Anticancer Action of Anticancer Peptides; 6.2.1 Sequence Length; 6.2.2 Net Positive Charge; 6.2.3 Hydrophobicity; 6.2.4 Amphiphilicity; 6.3 Membrane-Based Factors That Contribute to the Anticancer Action of ACPs; 6.3.1 Membrane Receptors 6.3.2 Cholesterol |
| Record Nr. | UNINA-9910829850203321 |
|
Phoenix David A
|
||
| Weinheim, : Wiley-VCH, c2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical pharmacokinetics
| Clinical pharmacokinetics |
| Pubbl/distr/stampa | [Langhorne, PA], : Adis International |
| Descrizione fisica | 1 online resource (volumes) |
| Disciplina | 615 |
| Soggetto topico |
Pharmacology
Pharmacokinetics Kinetics Pharmacocinétique Pharmacologie pharmacology |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Soggetto non controllato |
Pharmacology
Pharmacy |
| ISSN | 1179-1926 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996202236403316 |
| [Langhorne, PA], : Adis International | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Clinical pharmacokinetics
| Clinical pharmacokinetics |
| Pubbl/distr/stampa | [Langhorne, PA], : Adis International |
| Descrizione fisica | 1 online resource (volumes) |
| Disciplina | 615 |
| Soggetto topico |
Pharmacology
Pharmacokinetics Kinetics Pharmacocinétique Pharmacologie pharmacology |
| Soggetto genere / forma |
Periodical
Periodicals |
| Soggetto non controllato |
Pharmacology
Pharmacy |
| ISSN | 1179-1926 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910482002203321 |
| [Langhorne, PA], : Adis International | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Communication in Pharmacy Practice
| Communication in Pharmacy Practice |
| Autore | Susanne Kaae (Ed.) |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (146 p.) |
| Soggetto non controllato |
Pharmacy
Communication |
| ISBN | 3-03897-577-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910346845603321 |
|
Susanne Kaae (Ed.)
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current therapeutic research
| Current therapeutic research |
| Pubbl/distr/stampa | [Belle Mead, NJ], : Excerpta Medica, Elsevier Science |
| Disciplina | 615 |
| Soggetto topico |
Therapeutics
Drugs Pharmaceutical Preparations Médicaments Thérapeutique |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals. Périodiques. |
| Soggetto non controllato |
Medicine, Research & Experimental
Pharmacology Pharmacy |
| ISSN | 1879-0313 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996214205003316 |
| [Belle Mead, NJ], : Excerpta Medica, Elsevier Science | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Current therapeutic research
| Current therapeutic research |
| Pubbl/distr/stampa | [Belle Mead, NJ], : Excerpta Medica, Elsevier Science |
| Disciplina | 615 |
| Soggetto topico |
Therapeutics
Drugs Pharmaceutical Preparations Médicaments Thérapeutique |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals. Périodiques. |
| Soggetto non controllato |
Medicine, Research & Experimental
Pharmacology Pharmacy |
| ISSN | 1879-0313 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910134371003321 |
| [Belle Mead, NJ], : Excerpta Medica, Elsevier Science | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Flore Medicale Des Signatures XVIe - XVIIe Siecles
| Flore Medicale Des Signatures XVIe - XVIIe Siecles |
| Autore | Ducourthial |
| Pubbl/distr/stampa | Editions L'Harmattan |
| Descrizione fisica | 1 online resource (670 p.) : ill |
| Soggetto non controllato |
Pharmacy
Medical |
| ISBN | 2-14-001313-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | fre |
| Record Nr. | UNINA-9910149516003321 |
|
Ducourthial
|
||
| Editions L'Harmattan | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The International journal of pharmacy practice
| The International journal of pharmacy practice |
| Pubbl/distr/stampa | London, England, : Royal Pharmaceutical Society of Great Britain, ©1991- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Pharmacy
Drug Therapy Pharmaceutical Preparations Farmacie |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Soggetto non controllato | Pharmacy |
| ISSN | 2042-7174 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996218554703316 |
| London, England, : Royal Pharmaceutical Society of Great Britain, ©1991- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
